ZEISS Medical Ecosystem - Digital Solutions Roll-out

Microsurgery Robust growth despite continued supply chain strains 6M 2022/23 6M 2021/22 6M 2022/23 6M 2021/22 OPT Carl Zeiss Meditec Group 203.5 € 231.9 million +13.9% ☐ Revenue FX-adj. revenue growth of +12.7% Large order backlog amid slowly improving supply chain situation EBIT margin 22.6% " Gross margin improvement yoy despite rising procurement costs -2.3 pps " 24.9% EBIT margin reduced through continued high strategic investments in research & development MCS 23.8% of total revenue Revenue Split ZEISS Page 24

View entire presentation